FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
FSTX
Delisted
FSTX was delisted on the 8th of March, 2023.
43 hedge funds and large institutions have $53.2M invested in F-star Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
17% less call options, than puts
Call options by funds: $151K | Put options by funds: $183K
26% less capital invested
Capital invested by funds: $71.9M → $53.2M (-$18.6M)
Holders
43
Holding in Top 10
2
Calls
$151K
Puts
$183K
Top Buyers
| 1 | +$1.55M | |
| 2 | +$853K | |
| 3 | +$340K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$174K |
| 5 |
Millennium Management
New York
|
+$150K |
Top Sellers
| 1 | -$12.8M | |
| 2 | -$1.52M | |
| 3 | -$1.24M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$787K |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$20K |